Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. - Wikidata - awgldk - TriplyDB

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.

http://www.wikidata.org/entity/Q44415971

about

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!Renin-Angiotensin-aldosterone system in diabetes and hypertension Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Aldosterone production and insulin resistance in healthy adults The role of aldosteronism in causing obesity-related cardiovascular risk.Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review Increased aldosterone among HIV-infected women with visceral fat accumulation Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls Mineralocorticoid receptors modulate vascular endothelial function in human obesity Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations Abdominal obesity is characterized by higher pulse pressure: possible role of free triiodothyronine.Abnormal aldosterone physiology and cardiometabolic risk factors.Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system.Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults Adiposity has unique influence on the renin-aldosterone axis and blood pressure in black children.Management of patients with resistant hypertension: current treatment options.Resistant hypertension-complex mix of secondary causes and comorbidities The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.The role of aldosterone in the metabolic syndrome.A comprehensive review of the clinical aspects of primary aldosteronism.A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.Aldosterone and renin in cardiac patients referred for catheterization.Aldosterone Production and Signaling Dysregulation in Obesity.Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension.The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.

P2860

Q26776149-F846B089-96F7-48C6-BEE8-44DC3355271A Q28308222-E7BF4E28-B102-4C78-BE40-825ED0A60607 Q30248429-5F5F9602-4E69-4145-8EC1-C7F65848ED2F Q33786853-656C614C-4E91-4F3C-A725-3D0351BF74D9 Q33995992-A942F2F3-EB98-4FC6-AC08-60CA3C0CED77 Q34018585-6508D2F9-68B5-4A42-A476-72AAA6145AD1 Q34066641-ED00F0C9-A117-4AE9-A24C-E5E80F02CAB1 Q34220048-9CA8F497-FAB9-4175-930B-CD9C9E33C41B Q34714245-242734FE-4305-4F12-9B79-FF71F613F009 Q35026645-74349FBC-0711-4B25-8B25-10C98CA27392 Q35028637-2A3C6063-06CE-47D1-AD9C-25D3E79E8E09 Q35031976-3139C4C6-9756-46BE-ABEB-D1F230853C2E Q35792253-FBD5658F-2FA7-476E-8387-044078D15519 Q36297722-97B32008-93B4-4933-AC79-57267A2FB6F5 Q36308226-9B8DB171-8B01-44F1-9EA3-C41044B4C155 Q36737227-B8C0ED01-9770-4CE4-97F4-6A1289DFFDFA Q37039244-2757FF96-AC2E-4B15-8F27-4AC2EB782A70 Q37154403-ED828BE1-9FBB-4598-8F3C-12E2731F14AC Q37266193-6FBF0A5C-6777-4A99-A812-E44CD715AAF0 Q37304418-D500D54B-E2F4-4853-93EB-028437D0B4F5 Q37333220-68730917-98F2-4F7B-82F5-7D26EEA4D0F3 Q37475546-CB1D0022-07A1-4E0C-8B80-0DDBFBC6AEC6 Q37624307-239AFE5C-2987-49F5-B7BB-1D94DF119033 Q37833554-3EF27217-6972-49F2-9965-346DAD1CEA33 Q37879448-C9F240D3-8CA2-473B-A4D8-D0C1521CC224 Q38108677-0DA50A21-269C-4641-80E8-58EBD0305704 Q38151149-AE6207BF-8EEE-43DB-BA89-C6BA91058233 Q38262065-98246A08-7EF6-4BAC-BE39-AB44350359CE Q38267493-5BF0152F-955D-4177-9912-BE662B34636E Q38675419-BB41A6C7-0F28-47CA-ABAE-1F4911006AD7 Q38714084-AF284611-18D5-4C47-B10F-9DE00B7A200D Q38720544-AE45F84A-9ED0-4635-ADE8-E3701256B7BD Q38872907-03ED63A2-082E-4A77-A89E-B397A72254A4 Q38960042-91E5AAB7-1829-43EB-BF27-AE1C9EA8BDD8 Q39238938-CFAB8B52-0C27-4157-835F-41F12FA36E91 Q39322673-0C1EC916-CEFB-4EAE-B881-DAD671C6B228 Q40620899-1761074E-AA89-436F-9699-F8547FD9F6BA Q42759679-E1619410-F832-45FE-B98E-414D34F9096A Q43007154-535AFC55-0D98-4E8F-9B50-4CB82BEE1C6B Q43193916-40A8A6D1-600A-49C1-9CD2-18EB95ED85EE

P2860

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.

http://www.wikidata.org/entity/Q44415971

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Body mass index predicts plasm ...... primary hypertensive patients.

@en

Body mass index predicts plasm ...... primary hypertensive patients.

@nl

type

label

Body mass index predicts plasm ...... primary hypertensive patients.

@en

Body mass index predicts plasm ...... primary hypertensive patients.

@nl

prefLabel

Body mass index predicts plasm ...... primary hypertensive patients.

@en

Body mass index predicts plasm ...... primary hypertensive patients.

@nl

P1433

Q44415971-29119089-ECF8-4611-82BB-FB894AB84E01

P1476

Q44415971-E9A96B9D-F84F-4F1D-969C-4490CFBFEA08

P2093

Q44415971-03FF59CC-40B5-4ADC-8053-F54131B5C762

Q44415971-0E1120F7-42A9-424B-8B79-E5D34A24FA89

Q44415971-4D6317D8-E9B8-48B6-BC9F-0DCEA3566592

Q44415971-5B05349E-9F1D-4560-AB18-4B411FC3DF82

Q44415971-5C207A44-3C1B-4A6C-82B4-7E1449FEC683

Q44415971-64A87F40-4B6D-4B17-8631-3EB6DA5A163E

Q44415971-823202D6-32FC-4A7B-8FDD-EA987D746BE2

Q44415971-8E65EC17-57AA-44AC-947A-29149FE66871

Q44415971-A8056A12-CCAF-445C-B312-B8A22BF465D0

Q44415971-B46253FF-A5D7-4C22-9870-A6C79EF768EF

P304

Q44415971-847E5E62-2262-4675-910B-2EB72D0335A9

P31

Q44415971-7B9EEA32-6F47-4EF5-BAF5-E761D118775F

P356

Q44415971-F4502587-F8D0-4ED3-AD94-161C5EBEAFFA

P407

Q44415971-22A93AD6-6DE6-465A-B9D4-64F61F2FA233

P433

Q44415971-2BB6F85B-DE36-4FB8-A7B1-1A424CC9FB36

P478

Q44415971-5BDA2446-D369-45B0-AE40-5BD7A0C2DCF0

P50

Q44415971-0A89DD7B-5A22-44A5-8572-9C51CFCA330C

Q44415971-35CE5167-7FBC-4806-93D2-5252C92C3889

Q44415971-83636994-7399-4399-A5C3-E27D0DDBF980

Q44415971-BD935946-F82C-4DC5-AF51-ABD168AE879C

Q44415971-D27217BA-C07C-4823-8482-37DD8DB88632

P577

Q44415971-B2B9A1DA-4FE9-47C8-8F42-933FCB95FBB0

P5875

Q44415971-090BE3F1-076A-485E-BE9E-3F0D6A62A609

P698

Q44415971-3251E29E-2E79-4722-B31A-73FC7B32A975

P921

Q44415971-9D39AAE2-E39E-4F4E-882A-F5C91D5EDA9E

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Body mass index predicts plasm ...... primary hypertensive patients.

@en

P2093

Achille C Pessina

http://www.w3.org/2001/XMLSchema#string

Anna Belfiore

http://www.w3.org/2001/XMLSchema#string

Anna Patalano

http://www.w3.org/2001/XMLSchema#string

Damiano Rizzoni

http://www.w3.org/2001/XMLSchema#string

Ermanno Rossi

http://www.w3.org/2001/XMLSchema#string

Franco Mantero

http://www.w3.org/2001/XMLSchema#string

Gaetana Palumbo

http://www.w3.org/2001/XMLSchema#string

Giampaolo Bernini

http://www.w3.org/2001/XMLSchema#string

Gian Paolo Rossi

http://www.w3.org/2001/XMLSchema#string

Graziella Caridi

http://www.w3.org/2001/XMLSchema#string

P304

2566-2571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-0251

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Mannelli

Claudio Letizia

Gilberta Giacchetti

P577

2008-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5406126

http://www.w3.org/2001/XMLSchema#string

P698

18445663

http://www.w3.org/2001/XMLSchema#string

P921